| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |